STAT+: Pharmalittle: Pelosi tries last-ditch drug pricing proposal; Merck sees up to $7B in Covid pill sales in 2022
Merck forecast between $5 billion and $7 billion in sales of its Covid-19 pill through the end of 2022, assuming emergency use authorization is granted by U.S. regulators in December.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to help you get in the mood. And what, exactly, will you be doing? This remains a lovely time to take a spin through the countryside — perhaps the Great Pumpkin will be waiting. You can decide how to vote on Election Day, or convince someone to get vaccinated. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …
